Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -100.51% | 9.17% | 37.41% | 41.64% | 30.74% |
| Total Depreciation and Amortization | -3.57% | 6.58% | 4.17% | 8.33% | 55.56% |
| Total Amortization of Deferred Charges | 17.24% | 15.48% | 18.75% | 13.75% | -- |
| Total Other Non-Cash Items | -4.58% | -20.57% | -41.96% | -36.77% | -1.74% |
| Change in Net Operating Assets | 609.12% | 182.86% | 126.36% | -46.51% | 26.01% |
| Cash from Operations | -56.17% | 30.14% | 42.29% | 42.70% | 35.75% |
| Capital Expenditure | -- | 29.03% | 77.78% | 77.42% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 224.34% | 41.21% | 159.83% | 133.89% | -190.05% |
| Cash from Investing | 224.32% | 41.37% | 159.69% | 133.83% | -190.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.49% | 2,300.00% | -75.74% | -- | 10,830.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 98.32% | -- |
| Cash from Financing | -99.57% | 2,300.00% | -75.74% | 89.23% | -35.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 644.81% | 222.47% | 97.96% | 107.57% | -105.47% |